T80.82 - Complication of immune effector cellular therapy

Applicable to Complication of immune effector cellular therapy
The 2025 edition of ICD10-CM T80.82 became effective on October 1, 2024.
This is the American ICD10-CM version of T80.82 - other international versions of ICD10 T80.82 may differ.
T80.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code

code to identify the specific complication, such as:
cytokine release syndrome (D89.83-)
immune effector cell-associated neurotoxicity syndrome (G92.0-)

Inclusion Term

Complication of chimeric antigen receptor (CAR-T) cell therapy
Complication of IEC therapy

Type 2 Excludes

complication of bone marrow transplant (T86.0)
complication of stem cell transplant (T86.5)

The following codes above T80.82 contain annotation back-references that may be applicable to T80.82:

Chapter: S00-T88 Injury, poisoning and certain other consequences of external causes

Section: T80-T88 Complications of surgical and medical care, not elsewhere classified

Category: T80 Complications following infusion, transfusion and therapeutic injection

injection icd 10

effector icd 10

transfusion icd 10

poisoning icd 10

surgical icd 10

infusion icd 10

complication icd 10

therapeutic icd 10

cellular icd 10

Billable/Specific Code

Browse other similar CM codes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Please, give attribution to our website icd-10code.com